—

BrightSpring Health Services, Inc. Common Stock(BTSG)— 同类公司组

数据截至2026-11-03 — 评分每个交易日晚间重新计算。分组标准=首先为共同的Closelook指数成分,其次为行业。Closelook研究日记,不构成投资建议。

BrightSpring Health Services, Inc. Common Stock的Closelook综合评分为51/100,在同类公司组内排名第8位(共9家)——组内评分最高的是Halozyme Therapeutics Inc(73/100)。

名称综合动量质量估值信号距52周高点
BTSG BrightSpring Health Services, Inc. Common Stock51852938ok5.3%
HQY HealthEquity Inc62757040ok5.2%
VEEV Veeva Systems Inc Class A60957527neutral5.8%
HNGE Hinge Health, Inc.56996321ok1.7%
TEM Tempus AI, Inc. Class A Common Stock41881916bull24.8%
HALO Halozyme Therapeutics Inc73979438ok4%
ONC BeOne Medicines AG64836430info8.7%
ARGX argenx NV ADR63727429info16%
DXCM DexCom Inc63807935watch8.5%

评分为Closelook全部覆盖范围内的相对读数——方法论见公司评分说明。信号灯来自每日夜间信号看板。

FAQ · from the current data · as of 2026-11-03

Quick answers

BrightSpring Health Services, Inc. Common Stock在Closelook覆盖范围内的同类公司有哪些?

分组首先基于共同的Closelook指数成分,其次基于行业:HealthEquity Inc (HQY)、Veeva Systems Inc Class A (VEEV)、Hinge Health, Inc. (HNGE)、Tempus AI, Inc. Class A Common Stock (TEM)、Halozyme Therapeutics Inc (HALO)、BeOne Medicines AG (ONC)、argenx NV ADR (ARGX)、DexCom Inc (DXCM)。

BTSG相对同类公司的评分如何?

BrightSpring Health Services, Inc. Common Stock的综合评分为51/100,组内排名第8位(共9家),截至2026-11-03;组内最高综合评分为Halozyme Therapeutics Inc(73/100)。Closelook评分为研究日记读数,不构成评级或投资建议。

Related in the Closelooknet universe

then Health Information Services, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.